BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21664098)

  • 41. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.
    Xue LY; Hu N; Song YM; Zou SM; Shou JZ; Qian LX; Ren LQ; Lin DM; Tong T; He ZG; Zhan QM; Taylor PR; Lu N
    BMC Cancer; 2006 Dec; 6():296. PubMed ID: 17187659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinicopathological significance of expressions of RECK and MMP-2 in esophageal squamous carcinoma].
    Qi M; Li JS; Li Y
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):283-5. PubMed ID: 20510080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
    Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased WNT6 expression in tumor cells predicts unfavorable survival in esophageal squamous cell carcinoma patients.
    Zhang L; Yuan G; Fang Y; Qiu M; Lin J; Sun J; Yang D
    Int J Clin Exp Pathol; 2015; 8(9):11421-7. PubMed ID: 26617869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positive correlation of cysteine-rich 61 and target genes of Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    Wang P; Li L; Li T
    J Cancer Res Ther; 2016 Oct; 12(Supplement):19-22. PubMed ID: 27721245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer.
    Zhao Y; Yang H; Wang X; Zhang R; Wang C; Guo Z
    Ann Diagn Pathol; 2013 Dec; 17(6):483-5. PubMed ID: 23871415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.
    Kauppila JH; Takala H; Selander KS; Lehenkari PP; Saarnio J; Karttunen TJ
    Histopathology; 2011 Oct; 59(4):643-9. PubMed ID: 22014045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma.
    Huang X; Xiao DW; Xu LY; Zhong HJ; Liao LD; Xie ZF; Li EM
    Oncol Rep; 2009 Apr; 21(4):1123-9. PubMed ID: 19288017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of cyclophilin a expression in esophageal squamous cell carcinoma.
    Feng MX; Li JP; Wang H; Shen YX; Tan LJ; Wang Q; Wang YQ
    Genet Test Mol Biomarkers; 2015 Apr; 19(4):182-6. PubMed ID: 25420107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intratumoral polymorphonuclear granulocyte is associated with poor prognosis in squamous esophageal cancer by promoting epithelial-mesenchymal transition.
    Hu P; Wang G; Shen M; Zhang P; Zhang J; Du J; Liu Q
    Future Oncol; 2015; 11(5):771-83. PubMed ID: 25757681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of esophageal squamous cell carcinoma proteomics.
    Qi YJ; Chao WX; Chiu JF
    J Proteomics; 2012 Jun; 75(11):3129-37. PubMed ID: 22564818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of protease-activated receptor 2 expression in oesophageal squamous cell carcinoma.
    Wang X; Liu HT; Li S; Li K; Lin N; Fan QX; Zheng YL
    J Int Med Res; 2010; 38(4):1381-8. PubMed ID: 20926011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a novel clinicopathological marker JK-1 for human oesophageal carcinoma.
    Tang JC; Chan KW; Law SY
    Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):41-44. PubMed ID: 29937447
    [No Abstract]   [Full Text] [Related]  

  • 54. Resected esophageal squamous cell carcinoma.
    Rodríguez-Sanjuán JC; Val-Bernal F
    World J Surg; 1996 Jan; 20(1):115-6. PubMed ID: 8588402
    [No Abstract]   [Full Text] [Related]  

  • 55. pT2N0M0 esophageal squamous cell cancer: location, grade, and statistics.
    Rice TW; Blackstone EH
    J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1426-7. PubMed ID: 23499471
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyr61 is a potential prognostic marker for prostate cancer.
    Terada N; Kulkarni P; Getzenberg RH
    Asian J Androl; 2012 May; 14(3):405-8. PubMed ID: 22343491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MAGEA3 serves as an independent indicator for predicting the prognosis of ESCC.
    Liu S; Chen H; Ge X; Gao Z; Shi Y; Yang M
    Panminerva Med; 2021 Sep; 63(3):382-383. PubMed ID: 31355595
    [No Abstract]   [Full Text] [Related]  

  • 58. Reply to Dr. Weiskirchen.
    Grazioli S; Matute-Bello G
    Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(7):L749. PubMed ID: 26429904
    [No Abstract]   [Full Text] [Related]  

  • 59. Significance of secreted protein acidic and rich in cysteine expression in colorectal carcinoma.
    Kim YJ
    Ann Coloproctol; 2013 Jun; 29(3):87-8. PubMed ID: 23862123
    [No Abstract]   [Full Text] [Related]  

  • 60. From start to end: Phase separation and transcriptional regulation.
    Peng L; Li EM; Xu LY
    Biochim Biophys Acta Gene Regul Mech; 2020 Dec; 1863(12):194641. PubMed ID: 33017669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.